Andrew Fritz Email

VP Financial Planning and Analysis . Rhythm Pharmaceuticals

Current Roles

Employees:
373
Revenue:
$5.9M
About
Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity. Rhythm's lead product candidate is setmelanotide, a first-in-class melanocortin-4 receptor (MC4R) agonist. Rhythm supports The Genetic Obesity Project (GeneticObesity.com) and the GO-ID Genotyping Study (GeneticObesityID.com).
Rhythm Pharmaceuticals Address
222 Berkeley Street
Boston, MA
United States
Rhythm Pharmaceuticals Email

Past Companies

Rhythm Pharmaceuticals Inc.Vice President Financial Planning and Analysis
Akcea TherapeuticsSenior Director of Financial Planning & Analysis
Viant MedicalVice President, Franchise Finance